Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A

International Journal of Cancer

Volumn 67, Issue 2, 1996, Pages 303-310

  Warnier, Guy ^a,b   Duffour, Marie Thérèse ^c   Uyttenhove, Catherine ^a,b   Gajewski, Thomas F ^a,b,d   Lurquin, Christophe ^a,b   Haddada, Hedi ^c   Perricaudet, Michel ^c   Boon, Thierry ^a,b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CELL STIMULATION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNIZATION; MASTOCYTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INDUCTION;

ADENOVIRIDAE; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; BASE SEQUENCE; FEMALE; GENETIC VECTORS; HUMANS; IMMUNIZATION; MAST-CELL SARCOMA; MICE; MICE, INBRED DBA; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0029787296     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960717)67:2<303::AID-IJC24>3.0.CO;2-A     Document Type: Article

References (28)

1. BOËL, P., WILDMANN, C., SENSI, M.-L., BRASSEUR, R., RENAULD, J.-C., COULIE, P., BOON, T. and VAN DER BRUGGEN, P., BAGE, a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity, 2, 167-175 (1995).
2. BOON, T., CEROTTINI, J.-C., VAN DEN EYNDE, B., VAN DER BRUGGEN, P. and VAN PEL, A., Tumor antigens recognized by T lymphocytes. Ann. Rev. Immunol., 12, 337-365 (1994a).
3. BOON, T., VAN DEN EYNDE, B., HIRSCH, H., MORONI, C., DE PLAEN, E., VAN DER BRUGGEN, P., DE SMET, C., LURQUIN, C., SZIKORA, J.-P. and DE BACKER, O., Genes coding for tumor-specific rejection antigens. Cold Spring Harbor Symposia on Quantitative Biology: Molecular Genet- ics of Cancer, Vol. 59, 617-622. Cold Spring Harbor Laboratory, New York (1994b).
4. BOON, T., VAN SNICK, J., VAN PEL, A., UYTTENHOVE, C. and MARCHAND, M., Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T-lymphocyte-mediated cytolysis. J. exp. Med., 152, 1184-1193 (1980).
5. CONRY, R.M., LOBUGLIO, A.F., KANTOR, J., SCHLOM, J., LOECHEL, F., MOORE, S.E., SUMEREL, L.A., BARLOW, D.L., ABRAMS, S. and CURIEL, D.T., Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res., 54, 1164-1168 (1994).
6. CORDIER, L., DUFFOUR, M.-T., SABOURIN, J.C., LEE, M.G., CABANNES, J., RAGOT, T., PERRICAUDET, M. and HADDADA, H., Complete recovery of mice from a pre-established tumour by direct intratumoral delivery of an adenovirus vector harbouring the murine IL-2 gene. Gene Ther., 2, 16-21 (1995).
7. ESPEVIK, T. and NISSEN-MEYER, J., A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. immunol. Methods, 95, 99-105 (1986).
8. FELTKAMP, M.C.W., SMITS, H.L., VIERBOOM, M.P.M., MINNAAR, R.P., DE JONGH, B.M., DRIJFHOUT, J.W., TER SCHEGGET, J., MELIEF, C.J.M. and KAST, W.M., Vaccination with cytotoxic-T-lymphocyte-epitope-containing peptide protects against a tumor induced by humanpapillomavirus-type-16-transformed cells. Europ. J. Immunol., 23, 2242-2249 (1993).
9. GAJEWSKI, T.F., RENAULD, J.-C., VAN PEL, A. and BOON, T., Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine anti-tumor cytolytic T lymphocytes in vitro. J. Immunol., 154, 5637-5648 (1995).
10. GAUGLER, B., VAN DEN EYNDE, B., VAN DER BRUGGEN, P., ROMERO, P., GAFORIO, J.J., DE PLAEN, E., LETHÉ, B., BRASSEUR, F. and BOON, T., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. exp. Med., 179, 921-930 (1994).
11. GRAHAM, F.L., SMILEY, J., RUSSEL, W. and NAIRU, R., Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. gen. Virol., 36, 59-72 (1977).
12. HADDADA, H., RAGOT, T., CORDIER, L., DUFFOUR, M.-T. and PERRICAUDET, M., Adenoviral interleukin-2 gene transfer into P815 tumor cells abrogates tumorigenicity and induces anti-tumoral immunity in mice. Hum. Gene Ther., 4, 703-711 (1993).
13. HANSEN, M.B., NIELSEN, S.E. and BERG, K., Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. immunol. Methods, 119, 203-210 (1989).
14. IRVINE, K.R., MCCABE, B.J., ROSENBERG, S.A. and RESTIFO, N.P., Synthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic CTL. J. Immunol., 154, 4651-4657 (1995).
15. LETHÉ, B., VAN DEN EYNDE, B., VAN PEL, A., CORRADIN, G. and BOON, T., Mouse tumor-rejection antigens P815A and P815B: two epitopes carried by a single peptide. Europ. J. Immunol., 22, 2283-2288 (1992).
16. MANDELBOIM, O., VADAI, E., FRIDKIN, M., KATZ-HILLEL, A., FELDMAN, M., BERKE, G. and EISENBACH, L., Regression of established murine carcinoma metastases following vaccination with tumorassociated antigen peptides. Nature Med., 1, 1179-1183 (1995).
17. OSSEVOORT, M.A., FELTKAMP, M.C.W., VAN VEEN, K.J.H., MELIEF, C.J.M. and KAST, W.M., Dendritic cells as carriers for a cytotoxic-T-lymphocyte-epitope-based peptide vaccine in protection against a human-papillomavirus-type-16-induced tumor. J. Immunother., 18, 86-94 (1995).
18. RANDRIANARISON-JEWTOUKOFF, V. and PERRICAUDET, M., Recombinant adenoviruses as vaccines. Biologicals, 23, 145-157 (1995).
19. RAZ, E., CARSON, D.A., PARKER, S.E., PARR, T.B., ABAI, A.M., AICHINGER, G., GROMKOWSKI, S.H., SINGH, M., LEW, D., YANKAUCKAS, M.A., BAIRD, S.M. and RHODES, G.H., Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. not. Acad. Sci. (Wash.), 91, 9519-9523 (1994).
20. STRATFORD-PERRICAUDET, L.D., MAKEH, I., PERRICAUDET, M. and BRIAND, P., Widespread long-term gene transfer to mouse skeletal muscles and heart. J. clin. Invest., 90, 626-630 (1992).
21. TAKAHASHI, K., SHICHIJO, S., NOGUCHI, M., HIROHATA, M. and ITOH, K., Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res., 55, 3478-3482 (1995).
22. TAKEBE, Y., SEIKI, M., FUJISAWA, J.-I., HOY, P., YOKOTA, K., ARAI, K.-I., YOSHIDA, M. and ARAI, N., SRα promoter: an efficient and versatile mammalian cDNA expression system composed of the simian-virus-40 early promoter and the R-U5 segment of human T-cell-leukemia-virus-type-l long-terminal repeat. Mol. cell. Biol., 8, 466-472 (1988).
23. TOP, F.H., GROSSMAN, R.A., BARTELLONI, P.J., SEGAL, H.E., DUDDING, B.A., RUSSEL, P.K. and BUESCHER, E.L., Immunization with live type-7 and -4 adenovirus vaccines. I. Safety, infectivity, antigenicity and potency of adenovirus type-7 vaccine in humans. J. infect. Dis., 124, 148-154 (1971).
24. UYTTENHOVE, C., MARYANSKI, J. and BOON, T., Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigenloss variants rather than immunosuppression. J. exp. Med., 157, 1040-1052 (1983).
25. VAN DEN EYNDE, B., LETHE, B., VAN PEL, A., DE PLAEN, E. and BOON, T., The gene coding for a major tumor-rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. exp. Med., 173, 1373-1384 (1991).
26. VAN DEN EYNDE, B., PEETERS, O., DE BACKER, O., GAUGLER, B., LUCAS, S. and BOON, T., A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. exp. Med., 182, 689-698 (1995).
27. VAN DER BRUGGEN, P., TRAVERSARI, C., CHOMEZ, P., LUROUIN, C., DE PLAEN, E., VAN DEN EYNDE, B., KNUTH, A. and BOON, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643-1647 (1991).
28. YANG, Y., LI, Q., ERTL, H.C. and WILSON, J.M., Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol., 69, 2004-2015 (1995).